Shandong Bailong Chuangyuan Bio-Tech Co 605016.SS · CNY
Consumer Staples · Shanghai · 🇨🇳 China
19.56
-0.61%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Shandong Bailong Chuangyuan Bio-Tech Co
Its shares trade on Shanghai under the ticker 605016.SS. It has been listed since 21 April 2021. In the fiscal year to 31 December 2025, it reported revenue of CN¥1.38bn and net income of CN¥368.6m. At that date it held total assets of CN¥2.44bn and shareholders' equity of CN¥1.96bn.
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. engages in the research, development, production and sales of prebiotic, dietary fiber, and starch sugar & alcohol series products. The company is headquartered in Dezhou, Shandong. The company went IPO on 2021-04-21. The firm's main businesses include prebiotic series products, mainly including fructooligosaccharides, isomalt oligosaccharides, galacto-oligosaccharides, xylo-oligosaccharides; dietary fiber series products, mainly including resistant dextrin and polydextrose; other starch sugar (alcohol) products, mainly including maltitol, fructose syrup, and maltose syrup; and healthy sweetener products, mainly for the research and development, production and sales of allulose. The firm's main products are widely used in food, dairy products, infant milk powder, functional beverages, health care products, medicine, animal nutrition and feed industries.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Food Products
- Listed since
- 21 Apr 2021
- Employees
- 659
- Website
- sdblcy.com ↗
Leadership
Pay as last reported
- Hong Jian ZhuoGeneral Manager & Director, since 2008
- Dong Mei LiFinancial Director, since 2006
- Zhao Bo GanMember-Supervisory Board & Head-Technical, since 2007
- Xian Bao ShaoMember-Supervisory Board & Vice Head-Technical, since 2011
- De Xuan ZhaoDeputy General Manager, since 2007
- Wen Ping YuMember-Supervisory Board & Head-Workshop, since 2006
- Guang Peng DouDeputy General Manager, since 2006
- Jun WeiDeputy General Manager, since 2006
- De Shan ZhangMember-Supervisory Board & Project Manager, since 2006
- Lian Lian AnSecretary, Director & Deputy General Manager, since 2012
- An Guo ZhangChairman-Supervisory Board, since 2016
- Bao De DouChairman, since 2005
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Shandong Bailong Chuangyuan Bio-Tech produces prebiotic series products like fructooligosaccharides and galacto-oligosaccharides.
- The company's dietary fiber products include resistant dextrin and polydextrose for food and dairy applications.
- Shandong Bailong Chuangyuan Bio-Tech develops healthy sweeteners such as allulose for functional beverages and health care products.
Weaknesses
- The company's main products are limited to prebiotic, dietary fiber, and starch sugar series without diversification.
- Shandong Bailong Chuangyuan Bio-Tech has only 659 employees, which may limit scalability.
- The firm's focus on food and dairy industries restricts market expansion opportunities.
Opportunities
- The growing demand for functional beverages and health care products presents new market opportunities.
- Shandong Bailong Chuangyuan Bio-Tech can expand into animal nutrition and feed industries with existing products.
- The company can leverage its prebiotic series for infant milk powder applications in the food sector.
Threats
- The company's reliance on food and dairy industries exposes it to market volatility.
- Shandong Bailong Chuangyuan Bio-Tech faces competition from established players in the starch sugar market.
- The firm's limited product range may hinder growth in emerging health care markets.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.